Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 20, 2026 2.474
November 19, 2026 2.595
November 18, 2026 2.816
November 17, 2026 2.842
November 16, 2026 2.677
November 13, 2026 2.748
November 12, 2026 2.825
November 11, 2026 2.899
November 10, 2026 2.769
November 09, 2026 2.832
November 06, 2026 2.813
November 05, 2026 2.700
November 04, 2026 3.069
November 03, 2026 2.643
November 02, 2026 2.640
October 30, 2026 2.542
October 29, 2026 2.689
October 28, 2026 2.752
October 27, 2026 3.268
October 26, 2026 3.268
October 23, 2026 3.183
October 22, 2026 3.211
October 21, 2026 3.297
October 20, 2026 3.524
October 19, 2026 3.410
Date Value
October 16, 2026 3.325
October 15, 2026 3.496
October 14, 2026 3.382
October 13, 2026 3.410
October 12, 2026 3.467
October 09, 2026 3.481
October 08, 2026 3.467
October 07, 2026 3.410
October 06, 2026 3.439
October 05, 2026 3.439
October 02, 2026 3.410
October 01, 2026 3.439
September 30, 2026 3.496
September 29, 2026 3.644
September 28, 2026 3.674
September 25, 2026 3.703
September 24, 2026 3.703
September 23, 2026 3.644
September 22, 2026 3.850
September 21, 2026 3.820
September 18, 2026 3.820
September 17, 2026 3.879
September 16, 2026 3.791
September 15, 2026 3.850
September 14, 2026 4.026

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 16.42
Anika Therapeutics, Inc. 1.288
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.268

Price to Book Value Related Metrics

PS Ratio 2.683
Price 0.8707
Earnings Yield -8.61%
Market Cap 560.94M